Biogen (NASDAQ:BIIB) Releases Quarterly Earnings Results, Beats Expectations By $0.22 EPS
Biogen (NASDAQ:BIIB – Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported $3.67 earnings per share for the quarter, topping analysts’ consensus estimates of $3.45 by $0.22, Briefing.com reports. Biogen had a return on equity of 14.83% and a net margin of 12.07%. The firm had revenue of $2.29 billion […]